Immobilization of Therapeutic Deep Eutectic Solvents within fibers for drug delivery applications by Santos, Jorge Emídio Costa dos
 
 
Jorge Emídio Costa dos Santos 
Licenciado em Ciências de Engenharia em Micro e 
Nanotecnologias 
 
  
  
  
  
   
  
  
Immobilization of Therapeutic Deep 
Eutectic Solvents within fibers for drug 
delivery applications  
  
Dissertação para obtenção do Grau de Mestre em 
Engenharia de Micro e Nanotecnologias 
 
  
  
Orientador: Dr. Alexandre Babo de Almeida Paiva, Investigador 
Auxiliar, Departamento de Química, FCT NOVA. 
 
Coorientador: Dr. João Paulo Miranda Ribeiro Borges, Prof. 
Associado com Agregação Departamento de Ciências dos 
Materiais, FCT NOVA. 
  
  
  
   
  
  
 
 
 
 
 
 
 
 
  
  
  
  
 
 
 
 
 
Outubro, 2018
Immobilization of Therapeutic Deep Eutectic Solvents within fibers for drug delivery applications, 2018 
 
 
“The mind that opens to a new 
idea never returns to its 
original size.” 
Albert Einstein 
Immobilization of Therapeutic Deep Eutectic Solvents within fibers for drug delivery applications, 2018 
 
i 
 
Acknowledgements 
À minha família, minha mãe, meu pai, avós e irmão um enorme obrigado por todo 
o apoio e carinho ao longo destes anos. Sei que não foi fácil quando me deixaram aqui 
tão longe de casa e não tem sido fácil gerir a distância, mas obrigado por me terem apoiado 
nas minhas ambições e por estarem sempre lá quando preciso. Amo-vos imenso. 
A todos os meus professores, ao professor Geraldes um grande abraço de gratidão 
por todo o conhecimento que me transmitiu e especialmente pela amizade que ficou. À 
professora Dulce e à Manuela Rainho não há palavras que traduzam a gratidão que tenho 
para convosco, serão exemplos que levarei para a vida inteira. À Joana Pinto, à Ana 
Batista, professor Lavareda, professora Godinho, professora Susete, professor Pedro 
Batista um grande abraço e obrigado por tudo o que me ensinaram e por todo o apoio 
prestado. 
Aos meus orientadores, professor João Paulo Borges obrigado por todo o apoio e 
acompanhamento num dos maiores desafios que enfrentei até hoje. Obrigado por me ter 
disponibilizado o laboratório de biomateriais e o seu material e obrigado pela sua 
disponibilidade e entrega sempre que necessitei. Foi um privilégio trabalhar consigo e 
sem dúvida que gostaria de o voltar a fazer. Ao Alexandre que, apesar de sermos um 
pouco de mundos opostos, sempre se esforçou para me por à vontade com aquilo que eu 
não conhecia ou não compreendia muito bem, foi muito bom ter-te conhecido e ter 
trabalhado contigo, um muito obrigado. 
E por fim, a todos os meus amigos, que tornarão esta etapa a mais importante da 
minha vida até hoje. Ao Miguel Furtado, grande Miguel, obrigado pelas inúmeras 
discussões à volta do conteúdo das disciplinas e dos trabalhos, pelas explicações 
matemáticas e pela imensa camaradagem ao longo destes 5 anos. Ao Bolacha, à Sílvia, à 
Sofia Pádua, à Mariana, ao Duarte, à Bea, à Íris, ao Guilherme, ao Carapinha… epah, sem 
vocês o que era a FCT? À Kate, ao Ricardinho, à Raquel, ao André, à Inês, à Helena, ao 
Gabriel, à Mónica, ao Bubbles, não importa onde esteja, faça sol ou faça chuva, vocês 
são todos para a vida e mais não é preciso dizer, fizeram destes 5 anos uma aventura 
memorável e fantástica. Um grande obrigado a todos. 
Por último, mas não menos importante, um grande abraço a ti Catarina pela paz que 
me trazes, apoio e carinho que me dás. Desde que apareceste que fazes a diferença na tua 
forma única de me motivar a trabalhar quando não quero e ajudar quando estou triste. 
Obrigado por tudo o que és. E obrigado a Deus por ter posto todas estas pessoas 
maravilhosas na minha vida com as quais tive a oportunidade de crescer e de me tornar 
numa versão melhor de mim próprio. Grato do fundo do coração. 
  
Immobilization of Therapeutic Deep Eutectic Solvents within fibers for drug delivery applications, 2018 
 
ii 
 
  
Immobilization of Therapeutic Deep Eutectic Solvents within fibers for drug delivery applications, 2018 
 
iii 
 
Abstract 
The search for effective drug delivery systems has been subject of research over the 
last decades. Due the body´s many physiological barriers and the urgent need for 
increased bioavailability of active pharmaceutic ingredients (APIs), the efficient 
administration and therapeutic effect of a drug has become a great and important 
challenge nowadays. Transdermal drug delivery has recently gained attention in this field 
being mostly limited by the though barrier of the stratum corneum. Many studies have 
been conducted in order to enhance skin permeation of a drug and many transdermal 
patches are now available for commercial use due to its commodity and non-evasive 
properties. In this work, a therapeutic eutectic system designed to be effective at 
delivering ibuprofen through the skin was incorporated into a polymeric fibrous 
membrane produced by the Solution Blow Spinning method. An optimization of the 
fibrous membranes production was made, the impact of the Solution Blow Spinning 
parameters in fiber diameter was studied, retention capacity of the drug was evaluated as 
well as UV crosslinking efficiency and mechanical strength of the obtained membranes. 
The Solution Blow Spinning method showed to be simple and efficient at producing 
micrometric fibers with mean diameters ranging from 1 to 5 µm. The obtained membranes 
showed to be capable of retaining the eutectic drug but they were quite fragile and an 
overtime-controlled release was not achieved due to the polymer high solubility in water. 
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Resumo 
A busca de sistemas eficazes de administração de medicamentos tem sido alvo de 
investigação nas últimas décadas. Devido às muitas barreiras fisiológicas do corpo e à 
necessidade urgente de maior disponibilidade de medicamentos, a administração e efeito 
eficiente terapêutico de um medicamento tornaram-se num grande e importante desafio 
atualmente. A administração transdérmica de medicamentos ganhou recentemente muita 
atenção neste campo sendo maioritariamente limitada pela barreira da camada córnea. 
Muitos estudos foram conduzidos com o intuito de melhorar a permeação de um fármaco 
através da pele e muitos adesivos transdérmicos estão agora disponíveis para uso 
comercial devido à sua comodidade e propriedades não-evasivas. Neste trabalho, um 
sistema eutético terapêutico projetado para ser eficaz na administração de ibuprofeno 
através da pele foi incorporado numa membrana polimérica fibrosa produzida pelo 
método de Solution Blow Spinning. Efetuou-se a otimização da produção de membranas 
fibrosas, estudou-se o impacto dos parâmetros do método Solution Blow Spinning no 
diâmetro das fibras, avaliou-se a capacidade de retenção de fármaco das membranas, bem 
como a eficiência de reticulação UV e a resistência mecânica das membranas obtidas. O 
método Solution Blow Spinning mostrou-se simples e eficiente na produção de fibras 
micrométricas com diâmetros médios situados entre 1 e 5 µm. As membranas obtidas 
mostraram-se capazes de reter o fármaco eutético, mas são bastante frágeis e uma 
libertação controlada não foi conseguida devido à alta solubilidade do polímero usado na 
água. 
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Chapter 1 Introduction 
The development of effective treatments for diseases has been a major goal of 
humanity ever since. Over time, we have greatly improved our understanding of the 
human body and the functions of its various cooperating systems as well as the living 
cells that constitute their building blocks. The acquired knowledge has led to the 
development of a great variety of therapeutics, both natural and synthetic, to fight against 
infectious diseases, inflammatory illnesses, physical or mental disorders, and 
malfunctions of the body’s components. More than the drugs itself, we have been lately 
improving the delivery methods (Ulbrich et al., 2016). 
Although conventional drug delivery formulations have contributed greatly to the 
treatment of diseases, the emergence of new, potent and specific biological therapeutics 
has escalated the impetus for intelligent delivery systems. These systems must overcome 
many hurdles before clinical implementation is realized; a truly intelligent delivery 
system must address the need for specific targeting, intracellular transport, and 
biocompatibility while integrating elements of responsive behaviour to physiological 
environments (Liechty, Kryscio, Slaughter, & Peppas, 2010). 
1.1. Polymers and Drug Delivery 
Polymers have played an integral role in the advancement of drug delivery 
technology and have been tailored for modify transport or circulation, half-life 
characteristics, to allow for passive and active targeting and engineered to exert distinct 
biological functions. Such polymers have largely included cellulose derivatives, PEG 
(polyethylene glycol), and PVP (poly-N-vinylpyrrolidone) (Rowe, Sheskey, & Quinn, 
2009). As a water soluble synthetic polymer, PVP has many desirable properties 
including low toxicity, chemical stability, and good biocompatibility. It is also 
hemocompatible, physiologically inactive, non-irritating to skin, eye, and mucous 
membrane being used in many biomedical applications such as membranes, adhesives, 
ceramics, coatings and as a blood plasma substitute (Haaf, Sanner, & Straub, 1985; 
Liechty et al., 2010; Liu, Xu, Wu, & Chen, 2013; Smith, Rimmer, & MacNeil, 2006; 
Teodorescu & Bercea, 2015). 
1.2. Solution Blow Spinning (SBS) 
Polymeric micro and nanofibers production technology have gained wide interest 
because of its unique properties compared to larger diameter fibers made of the same 
material. Decreasing the diameter of fibers to the nanoscale markedly increases the 
surface area to volume ratio, increases liquid holding capacity, and changes texture and 
appearance. Nanofibers hold great promise for medical uses such as for tissue engineering 
scaffolds, controlled release of drugs and medications and as wound dressing for skin 
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regeneration (Huang, Zhang, Kotaki, & Ramakrishna, 2003; Ramakrishna, Fujihara, Teo, 
Lim, & Ma, 2005). 
Electrospinning (figure 1) of polymers was first reported with increasing intense 
research activity in recent years because of its adaptability to a wide range of polymeric 
materials and its consistency in producing very fine fibers. In the electrospinning process, 
an electrical charge is applied to a polymeric solution. At a point where the electrical 
forces created by the repulsion of positive charges on the solution overcomes the forces 
of surface tension, a fluid jet erupts and travels to a grounded collector. The high surface 
to volume ratio of the jet facilitates rapid evaporation of the solvent component and results 
in fine fibers that are randomly formed and can be collected to form a non-woven web 
(Huang et al., 2003; Ramakrishna et al., 2005). 
 
Figure 1: A schematic of an Electrospinning process (Huang et al., 2003). 
Even though electrospinning is considered the technique with the most potential for 
scaling to commercial production, the solvents that are compatible with the 
electrospinning process may be limited by their dielectric constant. 
SBS (figure 2) is a simple and rapid technique to produce nanofibers, using 
pressurized air-stream as driving force for fiber formation. The high velocity airflow used 
in SBS aids solvent evaporation for dry fiber production. Most published work on solution 
blow spinning involves the use of highly volatile organic solvents (or solvent mixtures). 
Spinning from low volatile solvents like water is challenging since the fibers may not 
fully dry before reaching the collector resulting on fiber defects (Daristotle, Behrens, 
Sandler, & Kofinas, 2016; Santos, Medeiros, Blaker, & Medeiros, 2016). 
SBS overcomes some drawbacks associated with the electrospinning process such 
as the use of an electric field. The method is therefore easily implemented using 
inexpensive, transportable, and handheld equipment. SBS allows for scalable production 
and deposition at the point and site of interest making this a reliable technique for 
emergency depositions. Applications of SBS in biomedical engineering are highlighted, 
showing enhanced cell infiltration and proliferation versus electrospun fiber scaffolds and 
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in situ deposition of biodegradable polymers (Daristotle et al., 2016; Medeiros, Glenn, 
Klamczynski, Orts, & Mattoso, 2009; Santos et al., 2016). 
Figure 2: An schematic of a SBS montage (left); the fiber jets formation at the nozzle exit 
(top right) and some examples of fibers obtained by a SBS method (down right) 
(Greenhalgh et al., 2017; Medeiros et al., 2009). 
1.3. Transdermal Drug Delivery 
Conventional drug delivery methods as oral and parenteral administration have 
limitations regarding physiological barriers through which the drug must pass. A 
transdermal drug delivery system (TDDS) is an appealing alternative to minimize and 
avoid the limitations allied with these drug administration methods. It consists in the 
permeation of drugs through the skin, into the systemic circulation, in a proper and 
prolonged steady-state delivery, avoiding the hepatic first-pass effect and reducing 
prospects of other side effects enhancing therapeutic efficacy (Barry, 1991; Kalluri & 
Banga, 2011). 
Polymers are utilized in TDDS in versatile manners of transdermal patches 
including as: rate-controlling membranes, adhesives, backing layers, and release liners. 
These patches are extremely commodious, user-friendly and provide the ease of 
termination if need arises (Alexander et al., 2012). 
The intact skin is a tough barrier and there are a lot of skin conditions affecting drug 
percutaneous absorption like solubility, lipophilicity, molecular weight or size, and 
hydrogen bonding. One of the most important factors is the intrinsic solubility of drug in 
the skin, this is closely related to the melting point of the drug, the membrane density and 
molecular weight, drug molecular weight and its entropy of fusion (Benson, 2005; Stott, 
Williams, & Barry, 1998). 
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Drug molecules in contact with the skin surface can penetrate by three potential 
pathways: through the sweat ducts, via the hair follicles and sebaceous glands 
(collectively called the shunt or appendageal route), or directly across the stratum 
corneum (figure 3). 
 
 
Figure 3: Possible pathways for drug permeation through the skin (left) and through the 
Stratum Corneum (right) (Benson, 2005; Hadgraft, 1979). 
Even though its known that permeation through the follicular shunt route most 
likely offers a steadier-state profile rather than the stratum corneum, the responsible 
appendages comprise a very small fractional area of about 0.1% and so their contribution 
to steady state flux of most transdermal drugs is minimal. This is why the majority of skin 
penetration enhancement techniques have being focused on increasing transport across 
the stratum corneum rather than via the appendages (Benson, 2005). 
Studies have shown that a reduction in the melting point of a permeant, which has 
been shown to be inversely proportional to lipophilicity, will increase its solubility in skin 
lipids and so increase transdermal permeation. So, if one can reduce the melting point of 
a drug without causing unfavourable changes to other physicochemical parameters, then 
this should enhance transdermal flux. As for the molecular weight is rather simple, as 
smaller the molecular weight (ideally less than 500 Da), easier is for the drug to permeate 
through the skin (Benson, 2005; Stott et al., 1998). 
 
Figure 4: Skin Permeation Enhancement/Optimization Techniques (Benson, 2005). 
Immobilization of Therapeutic Deep Eutectic Solvents within fibers for drug delivery applications, 2018 
5 
 
As shown in figure 4, one of the ways to reduce melting point of a substance is by 
eutectic formation. An eutectic is a substance generally composed of two or three solid, 
cheap and safe components that are capable of self-association, often through hydrogen 
bond interactions, to form a mixture with a resulting melting point lower than that of each 
individual component. These are generally liquid at temperatures lower than 100˚C and 
they are called of Deep Eutectic Solvents (DES) (Benson, 2005; Stott et al., 1998). 
It is possible to form a DES with an active pharmaceutical ingredient (API) and 
therefore increase the solubility, permeation and absorption of the API through the skin 
(Aroso et al., 2016; Stott et al., 1998). Those DES, which possess an API, are called 
THEDES (Therapeutic Deep Eutectic System). 
This work comes to report the optimization of the production of non-woven 
polymeric membranes of PVP impregnated with a THEDES using a coaxial SBS method. 
The THEDES used is a 3:1 molar ratio menthol:ibuprofen eutectic system in which the 
ibuprofen is the API and menthol is a well-recognized skin permeation enhancer (Babu 
& Pandit, 2005; Kunta, Goskonda, Brotherton, Khan, & Reddy, 1997). A study that came 
to analyse SBS parameters influence in fiber diameter will be presented. Furthermore, 
mechanical, swelling and DES release properties of the obtained membranes have been 
also studied. 
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Chapter 2 Materials and Methods 
2.1. PVP/DES solutions 
PVP (Sigma Aldrich, Mw = 1.300.000) dissolved in ethanol (Sigma Aldrich, 96%) 
solutions were used for fiber production. The solutions were prepared by dissolving 
different weight per volume (w/v) percentages of PVP into ethanol and magnetically 
stirred for 1h at room temperature until complete homogenization was achieved. Then the 
menthol:ibuprofen of 3:1 molar ratio DES was added also in weight per volume 
percentages and the final solution would remain at stirring for 2 more hours before use. 
Table 1 contains the used concentrations for PVP and DES in this work. 
Table 1: Used concentrations of PVP and DES. 
PVP Concentrations (w/v %) 6, 8, 10, 12, 14, 16, 18, 20, 22 
DES Concentrations (w/v %) 0.5, 1, 2 
2.2. Solution Blow Spinning (SBS) 
The SBS experiments were conducted using Linari 2 layers sealed coaxial system 
(COAX_2DISP), a digitally programmed syringe pump (kdScientific), a Nitrogen bottle 
as air supplier and a homemade rotative collector. The pump allowed to obtain solution 
flow rates ranging between 4 and 8 mL/h. As for the Nitrogen bottle, it allowed for 
consistent and regulated air pressures of 1; 2; 2.5 and 3 bar. The process was performed 
in open environment at room temperature with working distances (nozzle tip to collector 
distance) ranging between 15 and 20 cm. 
2.3. UV crosslinking and swelling 
The fibrous membranes were crosslinked with 254 nm ultraviolet light in a BIO-
LINK® irradiation system. The membranes were irradiated for 50 min (Faria, 2016). 
After the crosslinking, 3 pieces of each membrane for each DES concentration of 1 cm × 
1 cm dimensions were cut and submerged into 2mL of distilled water. The samples were 
left at 50˚C during 24h. 
2.4. Optical Microscopy (MO) and Scanning Electron Microscopy 
(SEM) 
Both MO and SEM were performed in order to analyse fiber morphology. For the 
SEM analysis, small pieces of the fibrous membranes were fixed on carbon tape and then 
mounted on a aluminium support to be sputtered with a thin layer of gold using a Q300T 
D Quorum sputter coater. The samples were analysed by a Zeiss DSM 962 scanning 
electron microscope. As for the MO analysis, fibrous membranes were directly deposited 
in glass covers that allowed them to be observed in a OLYMPUS BX 51 microscopy. The 
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diameter distribution of the obtained fibres was determined by using FIJI ImageJ 
software. 
2.5. UV-VIS Spectroscopy in Drug Delivery 
A T90+ UV/VIS Spectrophotometer from PG Instruments Ltd spectroscopy 
apparatus was used to analyse the drug delivery profile of the produced membranes. The 
delivery medium was a PBS (Phosphate Buffered Saline) solution adjusted for a 7.4 pH 
produced according a protocol offered by AAT Bioquest®. The used recipe data can be 
consulted in the section 6.4 of this work. 
The objective was to detect ibuprofen and so the wavelength of detection was set 
to 264 nm. First, in order to evaluate the ibuprofen release over time, samples of an entire 
membrane, for each DES concentration, submerged in 20 mL of PBS under magnetic 
stirring at 37˚C of temperature were collected at different times. Same procedure was 
made for crosslinked membranes. Then, five pieces of each non-crosslinked membranes 
were submerged in 2mL of PBS until its full dissolution and then collected. All samples 
collected were stored in eppendorfs and two quartz cuvets of 1 cm x 1 cm dimensions 
were used to place the samples into the spectrophotometer. The observation range was 
defined to be between 240 and 280 nm of wavelength. 
2.6. Mechanical assays 
Stress/Strain tests were performed in order to study non-woven mats mechanical 
behaviour. Three membrane samples were cut in small rectangular pieces of around 3 cm 
length and 1 cm width, mounted between a pair of iron clamps of a  Rheometric Scientific, 
Minimat Firmware 3.1 machine and then stretched at a speed of 1 mm/min. 
2.7. Rheology of the polymeric solutions 
The shear viscosities of the stock solutions were measured at 25˚C, in a shear range 
of 10−2 − 102 𝑠−1 using a Bohlin Gemini HRnano rotational rheometer equipped with a 
40 mm plate fixtures. The plate compressed the polymeric solutions up to a gap of 500 
µm and then applying a pre-shear to ensure a steady state. 
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Chapter 3 Results and discussion 
3.1. Fiber production and optimization 
One of the main objectives of this dissertation was to optimize the production of 
PVP fibrous membranes impregnated with a menthol:ibuprofen DES by using the SBS 
method. To do so, parameters like: polymer concentration, working distance, solution 
flow rate and air pressure were varied in specific range of values with the intention of 
achieving the lowest mean fiber diameter (MFD). The solvent used in the polymeric 
solutions was ethanol since it shown that can effectively dissolve both PVP and the DES 
simultaneously. In this work, all concentrations of both these components were 
weight/volume (w/v – g/mL) percentages. 
The ability to form fibers from a jet of polymer solution is primarily governed by 
the entanglement of polymer chains. It is known that concentration is proportional to fiber 
diameter and that this should be superior to the overlap concentration (C*) of the used 
polymer. The overlap concentration represents the critical point when polymer coils in 
solution begin to overlap, causing entanglements. Experiments have confirmed that SBS 
forms fibers when polymer concentration is superior to C* (C > C*), “beads-on-a-string” 
near C* (C ~ C*), and corpuscular morphologies below C* (C < C*). For the PVP with 
Mw = 1300000 g/mol, the overlap concentration value is around of 0.7% w/v (Yu, 2017). 
The air pressure and solution flow rate are dependant of viscosity of the polymeric 
solution and therefore of the polymer concentration. A higher solution viscosity needs a 
higher solution flow rate in order to prevent nozzle clogging and a bigger air pressure to 
be blown away forming fiber jets. The balance between air pressure and solution flow 
rate depends of the nature of the solvent and the polymer used. Fiber diameter is only 
affected by polymer solution flow rate at low gas pressures. However, low and high feed 
rates may cause jet instability or nozzle clogging, respectively. Increasing gas pressure 
produces a narrower fiber diameter distribution with less variance and consistent fiber 
morphology. However, increasing gas flow rate beyond the optimal range may also cause 
a temperature decrease around the polymeric jet which may cause poor solvent 
evaporation and fiber welding (Daristotle et al., 2016). 
At the work first stages, it was critical to determine the minimal polymer 
concentration which would allow for fiber formation using this method, polymeric 
solutions based only on PVP with concentrations of 6, 8 and 10% (w/v) were chosen to 
start the production. The solution flow rate was set to 6 or 8 mL/h, the air pressure set to 
1 or 2 bar and the working distance was fixed at 15 cm. PVP is a very hydrophilic polymer 
and, for these initial concentrations, only the 10% polymer concentration has allowed for 
well-defined fiber formation (figure 5), being the obtained membranes stewed with 
ethanol. 
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Figure 5: Optical microscopy images of a PVP membrane produced out of a 10% PVP 
concentration solution. 
When the first set of fibers was obtained, the first polymeric solutions with DES 
were made using the concentrations of 0.5%, 1% and 2% w/v. Using the same 
experimental conditions mentioned before, no effective fiber formation has been 
observed. It looked like the solvent was not properly evaporating resulting in a spray of 
polymeric residuals. To force solvent evaporation, polymer concentration and working 
distance were increased until good fiber formation was achieved. Polymer concentration 
was increased with a 2% increment, first to 12 and 14% using a working distance of 20 
cm. 
For the polymer concentrations of 12 and 14%, air pressures changing between 1 
or 2 bar, solution flow rates of 6 or 8 ml/h at a fixed working distance of 20 cm, good 
fiber formation was achieved for pure PVP (figure 6). Some other studies showed that, 
for the same system of PVP/ethanol, using very similar conditions as the ones mentioned 
before also resulted in good fiber formation and that, for pure PVP, this were most likely 
to be the best concentration range in order to achieve the smallest mean fiber diameter 
(Zhang, Kopperstad, West, Hedin, & Fong, 2009.).
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Figure 6: SEM image of a 14% pure PVP membrane. 
When the DES was added to the polymeric solutions of 12 and 14% PVP w/v 
respectively, once again, there was more of a spray than fiber formation due to poor 
solvent evaporation. To solve the current problem, it was chosen to increase the 
environment temperature in order to improve solvent evaporation. A hair dryer was added 
to the SBS montage (figure 7) which created a surrounding hot air stream that set the 
outer temperature of the nozzle, from which the polymeric solution flowed, to 
approximately 50˚C. 
 
Figure 7: SBS setup schematic. 
The hair dryer came to increase solvent evaporation and therefore fiber formation. 
However, the presence of agglutinated fiber domains dominated the area of the samples 
collected and analysed by SEM. This was most likely due to contact between the solution 
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jets before solvent was completely evaporated (Zhang et al., 2009.). The solution used to 
approach this issue was to increase even more the polymer concentration to values of 16, 
18, 20 and 22% w/v of PVP. 
  
Figure 8: SEM images of 14% PVP + 0.5% DES (left) and 16% PVP + 0.5% DES (right). 
Of these conditions, as it is observed on figure 8, the 16% polymer concentration 
shown yet to be ineffective at reducing fiber agglutination as the 18% proved to be the 
overall best, the 20% the second best and the 22% really unnecessary (figure 9) since, for 
most of the experiments made, the nozzle would constantly clog due to its very high 
viscosity.
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Figure 9: SEM imagens of a 18% PVP membrane (top left), a 20% PVP membrane (top 
right) and a 22% PVP membrane (bottom). 
3.2. Rheological behaviour of polymeric solutions 
It was clear that the DES caused some undesired effect that came to difficult solvent 
evaporation and therefore fiber formation, resulting in large domains of 
molten/agglutinated fibers. In order to test how the DES interacted with the polymeric 
solution, rheological studies were performed for the solutions of 18 and 20% PVP being 
the obtained results present in figure 10. 
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Figure 10: a) Flow curves of the 18% PVP solutions; b) Flow curves of the 20% PVP 
solutions. All assays were performed at 25˚C. 
By observing the obtained flow curves from the analysed samples, it is concluded 
that the obtained polymeric solutions exhibit a non-Newtonian behaviour typical of a 
pseudoplastic fluid with shear-thinning behaviour. In this kind of fluids, the viscosity 
decreases as the shear rate increases. This is caused by the structural reorganization of the 
fluid molecules due to the flow. Some common examples of pseudoplastics include 
ketchup, paints, even blood (Chhabra, 2010). 
As for the DES, it came to severely increase solution viscosity when added, making 
its blowing more difficult. This could inhibit the formation of well-defined fiber jets 
resulting in fiber welding (Daristotle et al., 2016; Medeiros et al., 2009). 
As mentioned before, the polymer concentration of 18% shown to be the best at 
ensuring the least of fiber welding at same time that keeps the lowest mean fiber diameter 
(MFD) possible. To support this affirmation, a study to analyse diameter variation and 
the impact of each operation parameter on diameter distribution was made. In this study, 
the different parameters were varied according to the values presented in table 2. 
Table 2: Range of operation of SBS parameters. 
Parameters Range of operation 
Polymer concentration 18%, 20% g/mL 
DES concentration 0.5%, 1%, 2% g/mL 
Solution flow rate 5, 6 mL/h 
Air pressure 2.5, 3 bars 
Distance to collector 20 cm 
3.3. Polymer concentration impact on fiber diameter 
The present section comes to present the obtained results of the polymer 
concentration impact in fiber formation and diameter. The data presented on figures 11 
a) b) 
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and 12 results of all the essays made for the 18% and 20% PVP concentrations 
respectively. 
  
Figure 11: Samples of a 18% PVP membrane (left) and a 20% PVP membrane (right)
 
 
Mean 
Standard 
Deviation 
Minimum Median Maximum 
2.911 2.284 0.340 2.237 13.830 
 
Mean 
Standard 
Deviation 
Minimum Median Maximum 
3.139 2.019 0.549 2.563 14.373 
Figure 12: Fiber diameter distribution for the different polymer concentrations and 
respective statistical results gathered for the 18% concentration (bottom left) and 20% 
concentration (bottom right).
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As it is possible to see from figure 12, a smallest MFD of 2.91 µm was obtained for 
the concentration of 18%. As for the concentration of 20%, a MFD of 3.14 µm was 
measured. The overall obtained fibers were inserted in the micrometric domain having 
very few nanofibers as is typical of the SBS method (Zhang et al., 2009.). It has to be 
mentioned that the problem of the fiber welding was never fully solved and such might 
be impossible to this set of components. 
3.4. DES concentration impact on fiber diameter 
The following figure 13, presents the data related to the study of the impact that the 
DES had on fiber diameter for the used concentrations of 0.5, 1 and 2% respectively. 
 
0.5% DES 
Mean 
Standard 
Deviation 
Minimum Median Maximum 
3.271 2.319 0.454 2.594 13.031 
 
1% DES 
Mean 
Standard 
Deviation 
Minimum Median Maximum 
3.497 2.291 0.340 2.830 15.869 
 
2% DES 
Mean 
Standard 
Deviation 
Minimum Median Maximum 
2.940 1.782 0.641 2.548 9.432 
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Figure 13: Fiber diameter distribution for the different DES concentrations and respective 
statistical results gathered. 
According to the results gathered and FTIR-ATR assays of the used polymeric 
solutions, there are not any signs of interactions between the eutectic substance and the 
polymeric chains, it is expectable that the DES has no significant impact on diameter of 
obtained fibers and that it comes only to cause jet instability resulting on fiber welding. 
This can be confirmed by the presented data in figure 13 and on figure 14 which shows 
that, for a fixed polymer concentration, the increase of DES concentration results in a 
decrease of fiber formation. 
  
 
Figure 14:Obtained SEM imagens of 18% PVP with 0.5% DES (top left), 1% DES (top 
right) and 2% DES (bottom). 
3.5. Solution flow rate impact on fiber diameter 
The solution flow rate does not really have a direct impact on fiber diameter but if 
too much increased, because there is a greater volume of solution to be blown away, might 
result in incomplete solvent evaporation and jet instability therefore resulting in defects 
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among the fibers (Daristotle et al., 2016; Faria, 2016). The statistical results obtained for 
the impact of the used solution flow rates on fiber diameter are presented in figure 15. 
 
Mean 
Standard 
Deviation 
Minimum Median Maximum 
3.033 2.094 0.340 2.464 13.830 
 
Mean 
Standard 
Deviation 
Minimum Median Maximum 
3.676 2.489 0.454 2.976 15.869 
 
Figure 15: Fiber diameter distribution and respective statistical results for the used 
solution flow rates of 5 mL/h (left) and 6 mL/h (right). 
The solution flow rate of 5 mL/h overall offered fibers with a lowest MFD of 3.03 
µm against the 6 mL/h flow rate which had MFD of 3.68 µm. This is probably due to the 
fact that a lower solution flow rate allows better solvent evaporation and less jet instability 
resulting in more well defined fiber production. However, it has to be reported that for 
the flow rate of 5 mL/h clogging of the nozzle occurred a few times giving to understand 
that, for this system, the optimal solution flow rate is somewhere between 5 and 6 mL/h. 
3.6. Air pressure impact on fiber diameter 
As mentioned before, a bigger gas pressure allows for a narrower fiber diameter 
distribution with less variance and consistent morphology. By the results present in the 
figure 16 such fact it is not observed. The 3 bar air pressure had a bigger MFD followed 
by a bigger deviation. This might indicate that the 3 bar (~ 45 psi) pressure might be out 
of the optimal range for fibre production, causing jet instability and preventing solvent 
from full evaporation (Daristotle et al., 2016; Zhang et al., 2009.). 
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Mean 
Standard 
Deviation 
Minimum Median Maximum 
3.215 1.854 0.340 2.658 12.326 
 
Mean 
Standard 
Deviation 
Minimum Median Maximum 
3.525 2.653 0.454 2.645 15.869 
 
Figure 16: Fiber diameter distribution for the used air pressures and respective statistical 
results gathered for the 2.5 bar (bottom left) and 3 bar (bottom right). 
To determine the optimal set of air flow and solution flow rate conditions, a few 
more experiments were made. By keeping the solution flow constant at 5 mL/h, the air 
pressure was varied to 1, 1.25, 1.5, 1.75, 2 and 2.5 bar. It was already concluded that, for 
the 5mL/h solution flow some clogging might occur at 2.5 bar indicating that it would be 
productive if the solution flow was increased or the air pressure was decreased for a bit. 
The mark of 1.75 bar was determined to be the minimal gas pressure necessary to form a 
jet with a 5 mL/h solution rate. By According to the literature, a smaller solution flow 
rate would allow a better solvent evaporation and a bigger air flow a smaller fiber 
diameter distribution (Daristotle et al., 2016). Logically, it would be productive the 
increase of the air flow at the limit of the turbulence regime and keeping the lowest 
possible solution flow rate in a way that no clogging was formed. It was decided to keep 
the air flow at 2.5 bar and gradually increase the solution flow rate to: 5.25, 5.50, 5.75 
and 6 mL/h. The determined optimal solution flow rate was around the value of 5.20 mL/h 
since this value allowed jet formation without clogging or any other disruptions. 
Therefore, the optimal determined SBS conditions for the used system (PVP + DES) are 
stated in the table 3.
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Table 3: The best determined parameters conditions for the SBS setup. 
PVP 
concentration 
Air pressure 
Solution flow 
rate 
Working 
Distance 
18% g/mL 2.5 bar 5.2 mL/h 20 cm 
The SBS method has allowed for the fabrication of PVP polymeric membranes 
impregnated with a DES. In order to ensure DES collection and protection, a 3 layer 
structure was chosen for the upcoming membranes. The mentioned structure consisted in 
a sandwich of two protective 18% pure PVP layers with the PVP + DES layer in the 
middle as is shown in figure 17. 
 
Figure 17: Representation of the final structure of the obtained membranes. 
3.7. Drug delivery 
In order to evaluate the drug delivery behaviour of the obtained membranes, a PBS 
(Phosphate Buffered Saline) solution was used as delivery medium in which the 
membranes were submerged. The liberation profile of the DES containing the ibuprofen 
was evaluated by UV-Vis Spectroscopy. The ibuprofen has an absorbance peak at around 
264 nm and correlation between the absorbance and concentration is according the Beer-
Lambert law (1) which states that there is a linear relation between the absorbance and 
concentration of a substance. 
𝐴𝑏𝑠 =  𝜀 × 𝑙 × 𝐶 (1) 
From here, we can build a calibration curve of concentration vs absorbance and 
create a regression equation that allows the ibuprofen concentration calculation (Sawale, 
Dhabarde, & Kar Mahapatra, 2016). The obtained calibration curve is available for 
consulting in the section 6. 
Several ways of testing the drug delivery behaviour of the obtained membranes 
were conducted. At first, a controlled drug delivery assay was made. The membranes 
were inserted into 20 mL of a 7.4 pH PBS buffer during 24h. Samples of 0.5 mL of the 
medium were collected at: 5, 10, 15, 30, 45, 60, 120, 180, 240, 300 min and a last one 
24h later in order to analyse the drug concentration profile over time. No significative 
absorbance peaks were detected from the collected samples indicating that the DES was 
extremely diluted or simply not present in the medium. 
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The mentioned assay was inconclusive also due to the fact that the membranes were 
completely dissolved in the medium after 1h to 1h:30. This was due to PVP high solubility 
in water resulting in full drug liberation in the time the dissolution occurred, being the 
delivery process mostly dependent of the erosion kinetics of the PVP polymeric chains 
(Fu & Kao, 2010). Trying to achieve a more controlled drug delivery behaviour, an UV 
crosslinking of the PVP membranes was made. Polymer crosslinking (in this case by UV 
light) consists in forming covalent bonds between polymeric chains with the objective of 
changing some of its physical properties. By crosslinking the PVP membranes, these 
turned resistant to dissolution, swelling into a hydrogel in the presence of water. In these 
terms, a hydrogel structure consists of networks that are formed from randomly 
crosslinked polymeric chains containing a polymeric-network matrix solid phase and a 
interstitial fluid phase. The hydrogel drug release behaviour is overall slower from the 
non-crosslinked PVP membranes because it is dependant of more factors like swelling 
and drug/solvent diffusion rates which are determined by the amount of liquid retained in 
the hydrogel, the distance between polymer chains and flexibility of those chains (Fu & 
Kao, 2010; Zarzycki, Modrzejewska, Nawrotek, & Lek, 2010). 
3.8. UV Crosslinking and Swelling capacity 
Based on the study done by Faria (Faria, 2016), an exposure time of 50 min at 254 
nm of wavelength in the irradiation chamber (figure 18) should effectively crosslinked 
the PVP chains. The UV-crosslinked membranes showed to have very good swelling 
behaviours both on water and ethanol absorbing the liquids and retaining them for several 
days without significant dissolution. 
 
Figure 18: UV crosslinking of polymeric membrane at irradiation chamber. 
To test the efficiency of the UV crosslinking, small pieces of one membrane for 
each DES concentration were cut and submerged on 2 mL of water quickly swelling and 
forming gels in its presence. Then the samples were placed in the heater during 24h for 
drying. Such procedure allows to determine the percentage of Sol/Gel mass of each 
membrane after the UV curing indicating if the used conditions promoted an effective 
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crosslink of the membranes. The Gel is the fraction of polymeric material that has been 
successfully crosslinked and managed to swell in the presence of water. As for the Sol 
fraction, it represents the fraction that was not crosslinked and therefore was flushed by 
the solvent. The obtained results are present in the following table. 
Table 4: Swelling capacity results of tested membranes. 
DES Concentration 0 0.5% 1% 2% 
% Gel 58.1 ± 1.1 44.6 ± 1.4 65.9 ± 0.7 65 ±1.2 
% Sol 41.9 ± 1.1 55.4 ± 1.4 34.1 ± 0.7 35 ± 1.2 
The obtained results show that the used crosslinking procedure was not completely 
successful and just being effective by around 2/3 of total of the polymeric chains as 
concluded from the obtained Gel percentages. In order to increase its effectiveness, the 
exposure time could be increased but Faria reported in his work that, for an exposure time 
of 60 min, cracks were visible in the fibers surface possibly indicating excessive UV 
exposure time. 
Thermal crosslinking of the membranes was also tried in this work. A PVP 
membrane was placed in the heater at 150˚C (Burnett & Heldreth, 2017) during 1h. After 
the procedure, the polymeric membrane presented a yellow colour and a strange scent. 
Such facts indicate that the DES was degraded, and this is not suitable for the purpose of 
this work. Other crosslinking methods consist in using chemical agents which may 
compromise the biocompatibility and integrity of our membranes and therefore were not 
considered. 
Although the crosslinking was not fully successful, the membranes did no longer 
dissolved themselves completely in the PBS. Instead, they quickly swelled in the medium 
making it denser and cloudy in a way that it was not possible to collect reliable samples 
to use in the spectrophotometer. 
At this point, it was still unclear if the impregnation of the DES within the PVP 
membranes was being successful using the coaxial SBS method. To ensure that there was 
DES among the fibrous membranes and to calculate how much of it, a different procedure 
was made. A single non-crosslinked membrane of each DES concentration was cut in five 
similar pieces that were individually dissolved at the end of approximately 30 min in 2mL 
of PBS. At first sight, there were some differences between the five obtained samples, 
some were cloudier than the others and had a much stronger menthol scent. Since the 
DES used was not soluble in water, when in contact with the PBS, a cloudy phase 
appeared. This was confirmed by mixing a few drops of the DES with water observing 
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the same effect. When these samples were analysed on the spectrophotometer, some of 
them needed to be diluted in order to fit into the Beer-Lambert law standards due to very 
high ibuprofen absorbance peaks. The obtained results for this experiment are present in 
table 5. 
Table 5: Results of the delivery of ibuprofen into PBS at room temperature. 
DES 
Concentration 
(% w/v) 
Dissolved 
membrane 
mass (mg) 
Abs at 
264 nm 
Dilution 
Factor 
Determined 
ibuprofen 
concentration 
(g/L) 
Ibuprofen 
released mass* 
(mg) 
Theorical 
ibuprofen 
mass** (mg) 
0.5 
115 - - - 
2.126 3.056 
102 0.767 1:2 0.764 
75 - - - 
64 - - - 
50 0.304 1:2 0.299 
1 
55 0.781 0 0.389 
3.318 6.111 
42 0.576 0 0.286 
54 0.742 0 0.369 
50 0.677 0 0.337 
41 0.56 0 0.278 
2 
65 0.75 1:4 1.493 
10.743 12.223 
52 0.46 1:4 0.911 
50 0.519 1:4 1.030 
44 0.434 1:4 0.859 
58 0.543 1:4 1.078 
*total mass of ibuprofen experimentally calculated that a whole membrane provided. 
**total theorical ibuprofen mass that a whole membrane could provide. 
The previous table shows the results obtained for all samples with well-defined 
absorbance peaks in the 264 nm region. Knowing the volume of our samples, by using 
our previous determined calibration curve equation and the Beer-Lambert law, it is 
possible to determine the amount (mass) of ibuprofen present in the samples. By summing 
up those values, we can obtain the total of ibuprofen in our entire membrane and compare 
it with the estimation made for the total possible mass that one membrane can have for 
each DES concentration. Those values are presented on the 2 rows at the right of the 
previous listed table and suggest that there are losses during the SBS process. Such fact 
it is of no surprise at all since the method was not performed in controlled and isolated 
environment and that there was, indeed, loss of fiber and certainly DES during the 
process. The fact that the biggest loss comes for the 1% concentration membrane is most 
likely due to a misalignment between the jet and the collector. 
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3.9. DES distribution analysis 
The fact that, for the concentration of 0.5%, some parts of the membrane had no 
significative absorbance peaks led to question if the DES distribution through the 
membrane was being uniform. To analyse this distribution, a total of 15 small pieces from 
different areas of the membrane were cut to analyse the DES distribution across the 
membrane. Figure 19 can show how the distribution was evaluated. 
 
 
Figure 19: Illustration of the approach taken into analysing DES distribution through the 
PVP membrane. 
The obtained absorbance results for all the samples collected are present in the 
figure 20. 
1 cm 
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DES concentration 
0.5% 1% 2% 
1 - 0.078 0.096 
2 0.055 0.050 0.119 
3 - - 0.127 
4 0.068 0.092 0.267 
5 0.030 - - 
6 - - 0.393 
7 0.101 0.049 0.241 
8 0.034 0.029 0.103 
9 - 0.029 0.213 
10 0.098 0.101 0.226 
11 - 0.021 0.228 
12 - 0.016 0.274 
13 0.150 0.168 0.487 
14 0.045 0.114 - 
15 0.138 - - 
 
 
Figure 20: Absorbance values in each site for each DES concentration (left) and average 
absorbance relation with the zone of the analysed membranes (right). 
By observing the data on the figure 20, it is possible to conclude that most of the 
DES is placed close to the centre of the membrane. On top of that, it is noticeable a slight 
discrepancy between the left and right-side values, however with no statistical 
significance. This slight difference must also probably be due to some jet oscillations 
during the SBS process and a misalignment between the polymer jet and the collector 
reinforcing the fact that the method needs to be done in a stable environment and 
conditions. However, as said before, the differences observed have no statistical 
significance. 
3.10. Mechanical tests 
To test the mechanical strength of the obtained 18% PVP membranes, Stress/Strain 
mechanical assays were made in the total of 3 for each membrane. The obtained stress 
curves are present in figure 21. 
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Figure 21: Obtained Stress/Strain graphs for each DES concentration membrane. 
From the obtained data, the Young modulus of each membrane was calculated 
(table 6) and the only objective conclusion gathered is that the membranes that were not 
submitted to UV curing have a more ductile behaviour than the ones crosslinked. This is 
no surprise since the crosslinking inhibits the reorganization and reorientation of the 
molecules according to the shear direction resulting in an increase of brittleness of the 
membrane (Nielsen, 2008). A ductile behaviour of the membrane is more desirable if the 
intention is to make an in situ deposition since the membrane have a bigger margin to 
adapt to surrounding forms and to resist to some movements without breaking. 
Since fiber deposition is a random process and fiber welding a constant in the 
process, the mechanical properties of the obtained membranes should present a 
considerable variance. Such fact is evident and confirmed by the obtained Young 
modulus values for the 1% and 2% DES crosslinked membranes presented in table 6.  
Future works should consider the use of more samples to have a meaningful statistical 
evaluation of the mechanical properties of these membranes.
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Table 6: Obtained Young modulus for each membrane. 
Sample Young modulus (E) 
0.5 DES 17.0 ± 6.8 MPa 
0.5% DES Crosslinked 16.1 ± 4.8 MPa 
1% DES 15.3 ± 3.4 MPa 
1% DES Crosslinked 27.5 ± 16 MPa 
2% DES 13.3 ± 6.7 MPa 
2% DES Crosslinked 37.7 ± 23 MPa 
  
Immobilization of Therapeutic Deep Eutectic Solvents within fibers for drug delivery applications, 2018 
28 
 
Chapter 4 Conclusions and future 
perspectives 
This dissertation reports the optimization of the production of PVP polymeric 
fibrous membranes impregnated with a menthol:ibuprofen 3:1 DES using the SBS 
method with the purpose of transdermal delivery of ibuprofen. The SBS method proved 
to be efficient at fiber fabrication at a faster pace than conventional electrospinning. 
However, the obtained fibers presented extensive welding as it is commonly observed in 
fibers produced by this method. 
Parameters like polymer concentration, air pressure, solution flow rate were varied 
and studied in order to obtain the minimum fiber diameter and the most consistent fiber 
formation in the presence of the eutectic component which came to complicate fiber 
formation. Regarding polymer concentration, the best concentration for producing pure 
PVP fibers with the minimum fiber diameter was determined to be placed between 12 
and 14% w/v. When the DES was added to the system, it increased solution viscosity 
causing instability on fiber jet formation at same time that prevented proper solvent 
evaporation, impairing fiber formation. Because of this, an hair-dryer was added to the 
SBS assembly in order to slightly increase the surrounding temperature of the jet up to 
50˚C and polymer concentration was increased to 18% to ensure the lowest mean fiber 
diameter while ensuring that fiber welding was reduced as much as possible. The polymer 
concentration proved to be the most important factor in fiber formation using the SBS 
method and the best SBS setup conditions to produce fibrous membranes from polymeric 
solutions with 0.5, 1 and 2% w/v DES were a 18% polymer concentration, a 2.5 bar air 
pressure and a 5.2 mL/h solution flow rate with a working distance of 20 cm to ensure 
that solvent was properly evaporated. Under these conditions, micrometric fibers with a 
mean fiber diameter ranging between 1 and 5 µm were obtained. Another feature of the 
obtained fibers was their helicoidal morphology. Even though the origin of the 
phenomenon was unknown, fibers with such morphology can be useful for other purposes 
since the superficial area per volume ratio increases. 
The produced polymeric membranes quickly dissolved themselves in water 
resulting in fast release of the DES into aqueous medium. In order to achieve a slower 
delivery profile, a UV crosslinking at 254 nm wavelength was performed, crosslinking 
the membranes up to approximately 60% of their total mass. The UV crosslinking allowed 
for the membranes to resist dissolution and instead swelling in the presence of water, 
being able to retain it for long periods of time (more than two weeks). In theory, this can 
retard drug delivery into the skin. A controlled release of the API was not achieved but if 
the polymer were deposited directly into the skin, the release rate would be severely 
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affected and dependent by the degradation ratio of the polymer itself. When PVP makes 
skin contact, it sticks to it and its easily degraded by it. It is assumed that, at same time 
the polymeric membrane is being degraded, it will release the DES into the skin (Fu & 
Kao, 2010). To be certain of this and to understand the ibuprofen delivery profile over 
time, more tests needed to be done. 
When in contact with the skin, according to supporting literature, our DES offers 
some advantages that come to enhance skin permeation. The already mentioned fact that 
by being an eutectic, and therefore by having a low melting point, has a higher lipid 
solubility increasing transdermal permeation. Regarding its chemical composition, 
menthol has been widely reported as good skin permeation enhancer. It is a low molecular 
weight molecule that can interact with the lipid structure of the skin disrupting the 
intercellular lipid structure and opening paths from which the APIs can pass. As for the 
ibuprofen itself, it is also a low molecular weight molecule with very low lipophilicity, 
so it penetrates through the skin relatively well. Other studies reinforce that the 
combination of these two components showed to be much more effective at permeating 
the skin than when not combined (Alexander et al., 2012; Barry, 1991; Sapra, Jain, & 
Tiwary, 2008; Stott et al., 1998; Williams & Barry, 2004). 
On top of this, mechanical stress/strain studies were performed. The mats did not 
present a stable mechanical behaviour and the only conclusions were that the membranes 
had an average Young modulus of 21.2 MPa and that the crosslinked membranes were 
more brickle than the non-irradiated ones. 
A possible way to obtain a lower mean fiber diameter was to use a SBS system in 
which the interior nozzle, the one through which the polymeric solution flowed, had an 
inferior diameter than the one used. This because a lower nozzle diameter would allow 
for lower fiber diameter as literature states. Also, instead of adding an hair-dryer to the 
montage, a previous warmed up air stream should be more practical. The achieved 
conclusions of the performed study show great promise for future developments of SBS 
systems for in situ depositions like, wound dressings, burning treatments, surgery 
coatings among others due to is versatility of use compared to the electrospinning process. 
For this specific subject, more studies need to be conducted regarding the DES liberation 
and skin permeation, but its encapsulation and protection was well succeeded giving the 
so much admired eutectic solvents new hopes of utility. 
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Chapter 6 Attachments 
6.1. Polymeric solutions preparation 
The following tables comes to present some of the quantities measured in the 
preparation of 5 mL of the polymeric solutions used in membranes fabrication. 
Table 7: Some experimental values of the measured mass of PVP for 18% PVP 
concentration. 
 Theorical value (g) Experimental value (g) 
1 
0.9000 
0.9045 
2 0.9127 
3 0.9023 
4 0.9171 
5 0.9183 
Table 8: Some experimental values of the measured mass of DES for 0.5% DES 
concentration. 
 Theorical value (g) Experimental value (g) 
1 
0.0250 
0.0312 
2 0.0424 
3 0.0295 
4 0.0337 
5 0.0361 
Table 9: Some experimental values of the measured mass of DES for 1% DES 
concentration. 
 Theorical value (g) Experimental value (g) 
1 
0.0500 
0.0628 
2 0.0612 
3 0.0573 
4 0.0569 
5 0.0635 
Table 10: Some experimental values of the measured mass of DES for 2% DES 
concentration. 
 Theorical value (g) Experimental value (g) 
1 
0.1000 
0.1231 
2 0.1201 
3 0.1045 
4 0.1172 
5 0.1153 
Table 11: Some experimental values of the measured mass of PVP for 20% PVP 
concentration. 
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 Theorical value (g) Experimental value (g) 
1 
1.0000g 
1.0343 
2 1.0012 
3 1.1592 
4 1.2837 
5 1.1726 
6.2. MFD values resulting from SBS optimization study 
Table 12: MFD for all variations done during the SBS process. 
Essay 
C PVP (g/mL 
%) 
C DES 
(g/mL%) 
Q sol 
(mL/h) 
Air Pressure 
(bar) 
MFD 
(µm) 
1 
18% 
0% 
5 
3 5.63 
2 2.5 1.77 
3 
6 
3 2.76 
4 2.5 5.03 
5 
0.5% 
5 
3 5.12 
6 2.5 2.82 
7 
6 
3 3.19 
8 2.5 1.73 
9 
1% 
5 
3 1.69 
10 2.5 2.08 
11 
6 
3 1.91 
12 2.5 3.05 
13 
2% 
5 
3 2.14 
14 2.5 2.80 
15 
6 
3 1.79 
16 2.5 2.73 
17 
20% 
0% 
5 
3 1.64 
18 2.5 1.84 
19 
6 
3 1.85 
20 2.5 3.36 
21 
0.5% 
5 
3 1.99 
22 2.5 3.00 
23 
6 
3 4.04 
24 2.5 3.34 
25 
1% 
5 
3 3.02 
26 2.5 2.9 
27 
6 
3 5.47 
28 2.5 3.68 
29 
2% 
5 
3 2.50 
30 2.5 4.64 
31 
6 
3 3.85 
32 2.5 2.87 
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6.3. Ibuprofen calibration curve 
The obtained calibration curve for ibuprofen in water is presented on figure 22 and 
the curve parameters are stated in table 7. 
 
 
Figure 22: Obtained calibration curve for ibuprofen release in aqueous medium. 
Table 13: Ibuprofen calibration curve parameters. 
Parameters Ibuprofen 
Detection wavelength 264 nm 
Linearity range 0.01-0.5 mg/mL 
Slope (𝑎) 1.99206 
Intercept (𝑏) 0.00617 
Correlation coefficient 0.99941 
Regression equation (y=ax+b) y=1.99206x+0.00617 
6.4. PBS solution recipe 
The respective components needed and measured to produce 1L of PBS solution, 
are presented in the following table. 
Table 14: PBS recipe components. 
Component Theorical mass value (g) Measured mass value (g) 
NaCl 8 8.0076 
KCl 0.2 0.2077 
Na2HPO4 1.44 1.4402 
KH2PO4 0.24 0.2464 
After its measure, each component was added to 1L of distilled water and placed in 
magnetic stirring for 1h. After that, the pH was adjusted to approximately 7.4 by adding 
a few drops of NaOH. 
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6.5. DES molecular weight and density 
Ibuprofen (C13H18O2) Mw = 206.285 g/mol 
Menthol (C10H20O) Mw = 156.269 g/mol 
DES 3:1 Menthol:Ibuprofen Mw = 675.092 g/mol 
Five samples of 0.5 mL of DES were collected and weighted. The obtained results 
are present in table  
Table 15: Mass values of each sample measured. 
 DES weight (mg) 
1 333 
2 429 
3 414 
4 433 
5 678 
DES density ≈ 457.4 ± 221 g/L 
